A Cohort Establishment Study of Total Management of Ovarian Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorSichuan Cancer Hospital and Research Institute
About this trial
A cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital;
Can cooperate with later follow-up.
Disqualifiers
Patients with other malignant tumors or previous history of other malignant tumors;
Have cognitive impairment.
Trial population
Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No intervention
Other interventionNo intervention
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Progress Freesurvival (PFS)
The time from the start of treatment until the patient progresses further or dies.
Time frame
Average six months after study completion.2
Overall Survival (OS)
Measure the time from the start of treatment to the time of death.
Time frame
Average six months after study completion.Secondary outcomes
1
Occurrence of adverse reactions
All adverse events were recorded.
Time frame
Average six months after study completion.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov